TCL Archive Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence December 26, 2008
TCL Archive Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients. April 9, 2010
TCL Archive Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies March 1, 1985